國家衛生研究院 NHRI:Item 3990099045/3227
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 857790      線上人數 : 819
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/3227


    題名: The Asian Vaccine Industry: Opportunities and challenges
    作者: Chong, P
    貢獻者: Vaccine Research and Development Center
    摘要: Asian governments are looking to Biotechnology to accelerate their food supplies and healthcare improvement, and some are even thinking about the economic growth through manufacturing valuable biological products. Companies and government agencies in Asia have been closing the gaps in regulatory compliance in manufacturing biologics in the last few years. However, countries such as China, Korea and India still lag behind in vaccine R&D and production techniques due to a lack of financial support and technology transfers from foreign companies. Emerging infectious diseases (pandemic avian influenza and global shortage of flu vaccines supply) have raised new challenges. They have changed the landscape of the vaccine industry. The processes involved in research to product launch normally take 7 to 13 years to go through multi-stage R&D and still have a low success rate. Today, novel technologies are being used and investigated for new vaccine developments.
    日期: 2008
    關聯: Pharma Focus Asia. 2008;6:42-46.
    Link to: https://www.pharmafocusasia.com/research-development/asian-vaccine-industry
    顯示於類別:[莊再成] 期刊論文

    文件中的檔案:

    沒有與此文件相關的檔案.



    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋